PEAK6
GILD icon

PEAK6’s Gilead Sciences GILD Stock Holding History

PEAK6’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.17M Buy
72,600
+32,100
+79% +$4.23M 0.02% 616
2026
Q1 		$5.64M Sell
40,500
-17,600
-30% -$2.46M 0.01% 841
2025
Q4 		$7.13M Buy
+58,100
New +$7.06M 0.01% 794
2025
Q2 		– Sell
-372,500
Closed -$41.7M – 3172
2025
Q1 		$41.7M Buy
372,500
+257,800
+225% +$26.6M 0.09% 179
2024
Q4 		$10.6M Buy
+114,700
New +$10.3M 0.02% 546

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PEAK6's GILD Position: Q2 2026 in Review

PEAK6 sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 7,597 shares — an estimated $1M sold.

PEAK6 first reported a position in GILD in Q1 2026 and held it in 1 quarter. The position peaked at $1.06M in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • PEAK6 reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • PEAK6 sold 7,597 Gilead Sciences shares in Q2 2026, an estimated $1M.
  • PEAK6 first reported a position in Gilead Sciences in Q1 2026 and held it in 1 quarter.
  • PEAK6's Gilead Sciences position peaked at $1.06M in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.